Literature DB >> 26305948

Structural basis of antizyme-mediated regulation of polyamine homeostasis.

Hsiang-Yi Wu1, Shin-Fu Chen1, Ju-Yi Hsieh2, Fang Chou1, Yu-Hsuan Wang2, Wan-Ting Lin3, Pei-Ying Lee3, Yu-Jen Yu1, Li-Ying Lin3, Te-Sheng Lin3, Chieh-Liang Lin1, Guang-Yaw Liu4, Shiou-Ru Tzeng5, Hui-Chih Hung6, Nei-Li Chan7.   

Abstract

Polyamines are organic polycations essential for cell growth and differentiation; their aberrant accumulation is often associated with diseases, including many types of cancer. To maintain polyamine homeostasis, the catalytic activity and protein abundance of ornithine decarboxylase (ODC), the committed enzyme for polyamine biosynthesis, are reciprocally controlled by the regulatory proteins antizyme isoform 1 (Az1) and antizyme inhibitor (AzIN). Az1 suppresses polyamine production by inhibiting the assembly of the functional ODC homodimer and, most uniquely, by targeting ODC for ubiquitin-independent proteolytic destruction by the 26S proteasome. In contrast, AzIN positively regulates polyamine levels by competing with ODC for Az1 binding. The structural basis of the Az1-mediated regulation of polyamine homeostasis has remained elusive. Here we report crystal structures of human Az1 complexed with either ODC or AzIN. Structural analysis revealed that Az1 sterically blocks ODC homodimerization. Moreover, Az1 binding triggers ODC degradation by inducing the exposure of a cryptic proteasome-interacting surface of ODC, which illustrates how a substrate protein may be primed upon association with Az1 for ubiquitin-independent proteasome recognition. Dynamic and functional analyses further indicated that the Az1-induced binding and degradation of ODC by proteasome can be decoupled, with the intrinsically disordered C-terminal tail fragment of ODC being required only for degradation but not binding. Finally, the AzIN-Az1 structure suggests how AzIN may effectively compete with ODC for Az1 to restore polyamine production. Taken together, our findings offer structural insights into the Az-mediated regulation of polyamine homeostasis and proteasomal degradation.

Entities:  

Keywords:  antizyme; antizyme inhibitor; ornithine decarboxylase; polyamine homeostasis; ubiquitin-independent proteolysis

Mesh:

Substances:

Year:  2015        PMID: 26305948      PMCID: PMC4568681          DOI: 10.1073/pnas.1508187112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

2.  Sedimentation velocity analysis of heterogeneous protein-protein interactions: sedimentation coefficient distributions c(s) and asymptotic boundary profiles from Gilbert-Jenkins theory.

Authors:  Julie Dam; Peter Schuck
Journal:  Biophys J       Date:  2005-04-29       Impact factor: 4.033

3.  HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes.

Authors:  Wladek Minor; Marcin Cymborowski; Zbyszek Otwinowski; Maksymilian Chruszcz
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-07-18

Review 4.  Regulation of ornithine decarboxylase.

Authors:  Anthony E Pegg
Journal:  J Biol Chem       Date:  2006-02-03       Impact factor: 5.157

5.  Solution structure of a conserved domain of antizyme: a protein regulator of polyamines.

Authors:  David W Hoffman; Donald Carroll; Nadia Martinez; Marvin L Hackert
Journal:  Biochemistry       Date:  2005-09-06       Impact factor: 3.162

6.  Polyamines regulate the expression of ornithine decarboxylase antizyme in vitro by inducing ribosomal frame-shifting.

Authors:  E Rom; C Kahana
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  A second mammalian antizyme: conservation of programmed ribosomal frameshifting.

Authors:  I P Ivanov; R F Gesteland; J F Atkins
Journal:  Genomics       Date:  1998-09-01       Impact factor: 5.736

Review 8.  Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases.

Authors:  Robert A Casero; Laurence J Marton
Journal:  Nat Rev Drug Discov       Date:  2007-05       Impact factor: 84.694

9.  Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.

Authors:  S Iwata; Y Sato; M Asada; M Takagi; A Tsujimoto; T Inaba; T Yamada; S Sakamoto; J Yata; T Shimogori; K Igarashi; S Mizutani
Journal:  Oncogene       Date:  1999-01-07       Impact factor: 9.867

10.  Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme.

Authors:  S Matsufuji; T Matsufuji; Y Miyazaki; Y Murakami; J F Atkins; R F Gesteland; S Hayashi
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

View more
  28 in total

1.  Structure of human Fe-S assembly subcomplex reveals unexpected cysteine desulfurase architecture and acyl-ACP-ISD11 interactions.

Authors:  Seth A Cory; Jonathan G Van Vranken; Edward J Brignole; Shachin Patra; Dennis R Winge; Catherine L Drennan; Jared Rutter; David P Barondeau
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-20       Impact factor: 11.205

Review 2.  Polyamines in mammalian pathophysiology.

Authors:  Francisca Sánchez-Jiménez; Miguel Ángel Medina; Lorena Villalobos-Rueda; José Luis Urdiales
Journal:  Cell Mol Life Sci       Date:  2019-06-21       Impact factor: 9.261

3.  Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer.

Authors:  Yi Qu; Jan Roger Olsen; Xing Yuan; Phil F Cheng; Mitchell P Levesque; Karl A Brokstad; Paul S Hoffman; Anne Margrete Oyan; Weidong Zhang; Karl-Henning Kalland; Xisong Ke
Journal:  Nat Chem Biol       Date:  2017-10-30       Impact factor: 15.040

Review 4.  Substrate selection by the proteasome through initiation regions.

Authors:  Takuya Tomita; Andreas Matouschek
Journal:  Protein Sci       Date:  2019-05-23       Impact factor: 6.725

Review 5.  Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use.

Authors:  John F Atkins; Gary Loughran; Pramod R Bhatt; Andrew E Firth; Pavel V Baranov
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

6.  Antizyme inhibitor 1 genetic polymorphisms associated with diabetic patients validated in the livers of diabetic mice.

Authors:  Cheng-Hsu Chen; Yeh-Han Wang; Shang-Feng Tsai; Tung-Min Yu; Shih-Yin Chen; Fuu-Jen Tsai
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

7.  Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity.

Authors:  Joshua D Ochocki; Sanika Khare; Markus Hess; Daniel Ackerman; Bo Qiu; Jennie I Daisak; Andrew J Worth; Nan Lin; Pearl Lee; Hong Xie; Bo Li; Bradley Wubbenhorst; Tobi G Maguire; Katherine L Nathanson; James C Alwine; Ian A Blair; Itzhak Nissim; Brian Keith; M Celeste Simon
Journal:  Cell Metab       Date:  2018-05-10       Impact factor: 27.287

Review 8.  The antizyme family for regulating polyamines.

Authors:  Chaim Kahana
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

Review 9.  Polyamine metabolism and cancer: treatments, challenges and opportunities.

Authors:  Robert A Casero; Tracy Murray Stewart; Anthony E Pegg
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

Review 10.  Polyamine Homeostasis in Development and Disease.

Authors:  Shima Nakanishi; John L Cleveland
Journal:  Med Sci (Basel)       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.